Anhui Huaheng Biotechnology Co., Ltd. (SHA:688639)
China
· Delayed Price · Currency is CNY 28.23
+0.71 (2.58%)
Apr 29, 2026, 3:00 PM CST
SHA:688639 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Operating Revenue | 2,395 | 2,311 | 1,805 | 1,704 | 1,220 | 841.86 | Upgrade
|
| Other Revenue | 551.16 | 551.16 | 372.99 | 234.23 | 198.65 | 112.23 | Upgrade
|
| Revenue | 2,946 | 2,862 | 2,178 | 1,938 | 1,419 | 954.1 | Upgrade
|
| Revenue Growth (YoY) | 24.61% | 31.40% | 12.37% | 36.63% | 48.69% | 95.81% | Upgrade
|
| Cost of Revenue | 2,360 | 2,270 | 1,639 | 1,156 | 870.26 | 646 | Upgrade
|
| Gross Profit | 586.29 | 591.62 | 538.54 | 782.37 | 548.39 | 308.1 | Upgrade
|
| Selling, General & Admin | 274.25 | 276.29 | 220.37 | 172.08 | 142.22 | 79.93 | Upgrade
|
| Research & Development | 152.33 | 151.2 | 124.05 | 108.82 | 78.61 | 52.84 | Upgrade
|
| Other Operating Expenses | 7.92 | 8.06 | -13.41 | 4.55 | 7.97 | 6.58 | Upgrade
|
| Operating Expenses | 433.86 | 434.9 | 329.79 | 285.77 | 231.29 | 139.03 | Upgrade
|
| Operating Income | 152.43 | 156.72 | 208.75 | 496.6 | 317.1 | 169.06 | Upgrade
|
| Interest Expense | -43.83 | -43.83 | -37.87 | -10.64 | -0.54 | -1.11 | Upgrade
|
| Interest & Investment Income | 6.56 | 6.79 | 5.25 | 5.91 | 10.64 | 7.5 | Upgrade
|
| Currency Exchange Gain (Loss) | -2.94 | -2.94 | 14.04 | 7.06 | 5.43 | -0.16 | Upgrade
|
| Other Non Operating Income (Expenses) | -17.94 | -4.73 | -3.3 | -2.66 | -0.59 | -0.39 | Upgrade
|
| EBT Excluding Unusual Items | 94.15 | 112.01 | 186.87 | 496.27 | 332.04 | 174.91 | Upgrade
|
| Gain (Loss) on Sale of Investments | -1.06 | -0.92 | - | -0.31 | -0.75 | 1.06 | Upgrade
|
| Gain (Loss) on Sale of Assets | 0.11 | 0.12 | -0.06 | -2.67 | -4.62 | -0.36 | Upgrade
|
| Asset Writedown | -2.61 | -1.86 | -0.31 | - | - | -5.61 | Upgrade
|
| Other Unusual Items | 16.2 | 16.2 | 14.9 | 12.98 | 16.32 | 20.78 | Upgrade
|
| Pretax Income | 106.78 | 125.56 | 201.41 | 506.27 | 342.98 | 190.79 | Upgrade
|
| Income Tax Expense | -5.47 | 1.7 | 16.85 | 59.67 | 23.64 | 22.55 | Upgrade
|
| Earnings From Continuing Operations | 112.25 | 123.86 | 184.56 | 446.6 | 319.34 | 168.24 | Upgrade
|
| Minority Interest in Earnings | 11.17 | 8.55 | 4.96 | 2.46 | 0.69 | - | Upgrade
|
| Net Income | 123.41 | 132.41 | 189.52 | 449.06 | 320.03 | 168.24 | Upgrade
|
| Net Income to Common | 123.41 | 132.41 | 189.52 | 449.06 | 320.03 | 168.24 | Upgrade
|
| Net Income Growth | -19.88% | -30.13% | -57.80% | 40.32% | 90.23% | 38.92% | Upgrade
|
| Shares Outstanding (Basic) | 248 | 250 | 231 | 229 | 227 | 208 | Upgrade
|
| Shares Outstanding (Diluted) | 248 | 250 | 231 | 229 | 227 | 208 | Upgrade
|
| Shares Change (YoY) | 6.31% | 8.10% | 0.88% | 0.72% | 9.33% | 22.57% | Upgrade
|
| EPS (Basic) | 0.50 | 0.53 | 0.82 | 1.96 | 1.41 | 0.81 | Upgrade
|
| EPS (Diluted) | 0.50 | 0.53 | 0.82 | 1.96 | 1.41 | 0.81 | Upgrade
|
| EPS Growth | -24.64% | -35.37% | -58.16% | 39.31% | 73.99% | 13.35% | Upgrade
|
| Free Cash Flow | -611.03 | -532.18 | -723.72 | -967.75 | -98.92 | -84.93 | Upgrade
|
| Free Cash Flow Per Share | -2.46 | -2.13 | -3.13 | -4.22 | -0.43 | -0.41 | Upgrade
|
| Dividend Per Share | 0.160 | 0.160 | 0.250 | 0.621 | 0.428 | 0.262 | Upgrade
|
| Dividend Growth | -36.00% | -36.00% | -59.72% | 44.99% | 63.33% | 63.51% | Upgrade
|
| Gross Margin | 19.90% | 20.67% | 24.73% | 40.36% | 38.66% | 32.29% | Upgrade
|
| Operating Margin | 5.17% | 5.48% | 9.59% | 25.62% | 22.35% | 17.72% | Upgrade
|
| Profit Margin | 4.19% | 4.63% | 8.70% | 23.17% | 22.56% | 17.63% | Upgrade
|
| Free Cash Flow Margin | -20.74% | -18.60% | -33.23% | -49.93% | -6.97% | -8.90% | Upgrade
|
| EBITDA | 386.27 | 371.52 | 347.41 | 595.44 | 376.25 | 216.56 | Upgrade
|
| EBITDA Margin | 13.11% | 12.98% | 15.95% | 30.72% | 26.52% | 22.70% | Upgrade
|
| D&A For EBITDA | 233.83 | 214.8 | 138.66 | 98.84 | 59.15 | 47.5 | Upgrade
|
| EBIT | 152.43 | 156.72 | 208.75 | 496.6 | 317.1 | 169.06 | Upgrade
|
| EBIT Margin | 5.17% | 5.48% | 9.59% | 25.62% | 22.35% | 17.72% | Upgrade
|
| Effective Tax Rate | - | 1.35% | 8.37% | 11.79% | 6.89% | 11.82% | Upgrade
|
| Revenue as Reported | 2,862 | 2,862 | 2,178 | 1,938 | 1,419 | 954.1 | Upgrade
|
| Advertising Expenses | - | 4.58 | 4.84 | 3.33 | 1.33 | 0.7 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.